This event is endorsed by ECCO
CIPROM2021/044
PROGRAMME
THURSDAY 26TH OCTOBER 2023
8:30 – 9:00 AM: Registration
9:00 AM: Welcome & overview of the workshop
9:15 – 10:30 AM: FIBROSIS: STATE-OF-THE-ART
Chairs: Jordi Gracia-Sancho (IDIBAPS, Barcelona) & Marta Maia Boscá-Watts (H. Clínico Universitario, Valencia)
– 9:15 – 9:53 AM: Mechanisms and clinical trial endpoints for structuring Crohn’s disease. Florian Rieder (Cleveland Clinic Foundation, Ohio)
– 9:53 – 10:30 AM: Liver fibrosis in ALD and NAFLD. Ramón Bataller (Hospital Clínic Barcelona)
10:30 -11:00 AM: Coffee break
11:00 AM – 2:00 PM: FACTORS INFLUENCING THE DEVELOPMENT OF FIBROSIS
Chairs: Rubén Francés (FISABIO-H. General Universitario, Alicante) & Ana Blas-García (University of Valencia)
– 11:00 – 11:24 AM: Sinusoidal communication in liver fibrosis. Anabel Fernández-Iglesias (IDIBAPS, Barcelona)
– 11:24 – 11:48 AM: Epigenetics. Maite García Fernández-Barrena (CIMA-Universidad de Navarra, Pamplona)
– 11:48 – 12:12 AM: Regulation of fibroblast-monocyte interactions: how do we TWEAK the system? Mario C. Manresa (University College Dublin)
– 12:12 – 12:36 PM: Lipotoxicity and fibrosis. Fabio Marra (University of Florence)
– 12:36 – 1:00 PM: Autophagy in liver fibrosis. Nadezda Apostolova (University of Valencia)
1:00 – 2:30 PM: Lunch
2:30 – 4:00 PM: CUTTING-EDGE APPROACHES TO THE STUDY OF FIBROSIS
Chairs: Javier Cubero (U. Complutense, Madrid) & Azucena Salas (Hospital Clínic Barcelona)
– 2:30 – 2:53 PM: Hepatic pathways in NAFLD progression: insights from multi-omics approaches. Olivier Govaere (KU Leuven, Leuven)
– 2:53 – 3:15 PM: Multi-omics in IBD: overview of observations and take-aways. Urko M. Marigorta (CICBioGUNE, Bilbao)
– 3:15 – 3:38 PM: Using iPSCs to understand liver fibrosis. Pau Sancho-Bru (IDIBAPS, Barcelona)
– 3:38 – 4:00 PM: Biomarkers in IBD. Marianne Spalinger (University Hospital Zurich)
4:00 – 4:30 PM: Coffee break
4:30 – 5:30 PM: FIBROSIS IN OTHER ORGANS AND TISSUES
Chairs: Sara Calatayud (University of Valencia) & Elena Ortiz (University of Valencia)
– 4:30 – 4:50 PM: Mechanisms of old fibrosis by impaired degradation. Antonio Vidal-Puig (Wellcome-MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, University of Cambridge)
– 4:50 – 5:10 PM: Impact of diffuse myocardial fibrosis in heart failure. Arantxa González Miqueo (CIMA, University of Navarra, Pamplona)
– 5:10 – 5:30 PM: Role of cellular senescence in the development of lung fibrosis. Jacobo Sellares (Hospital Clínic Barcelona)
6:00 – 8:00 PM: Tour of the city
8:00 PM: Drinks and canapés
FRIDAY 27TH OCTOBER 2023
9:00 – 11:00 AM: ORAL PRESENTATIONS
Chairs: David Martí-Aguado (Hospital Clínico Universitario, Valencia) & Jesús Cosín (University of Valencia)
11:00 – 11:30 AM: Coffee Break
11:30 AM – 1:30 PM: THERAPEUTIC APPROACHES TO FIBROSIS
Chairs: Jaume Bosch (University of Bern) & Ana Gutiérrez (H. General Universitario, Alicante)
– 11:30 – 12:00 AM: Characterization of molecular targets in ileal fibrosis: a starting point for the development of new therapies. María Dolores Barrachina (University of Valencia)
– 12:00 – 12:30 PM: Clinical trials NAFLD-fibrosis. Manuel Romero-Gómez (Hospital Virgen del Rocío-IBiS, Seville)
– 12:30 – 1:00 PM: Treating fibrosis in IBD: challenge for the gastroenterologist. Marta-Maia Boscá-Watts (Hospital Clínico Universitario, Valencia)
– 1.00 – 1:30 PM: Management of cirrhosis. Rafael Bañares (Hospital Gregorio Marañón, Madrid)
1:30 -1:45 PM: Best Communication Award and concluding remarks
2:00 – 3:30 PM: Lunch